Skip to main content

Table 2 Baseline levels of cardiometabolic markers according to serum 25(OH)D concentrations among participants with OA

From: L-shaped association of serum 25-hydroxyvitamin D concentrations with cardiovascular and all-cause mortality in individuals with osteoarthritis: results from the NHANES database prospective cohort study

 

Serum 25(OH)D concentrations (nmol/L)

P-value

< 25.00

25.00–49.99

50.00–74.99

≥ 75.00

Glycohemoglobin (%)

6.11 ± 1.00

6.01 ± 1.17

5.81 ± 0.88

5.76 ± 0.72

<0.01

Glucose, refrigerated serum (mg/dL)

107.38 ± 37.24

111.62 ± 48.65

103.66 ± 33.25

102.25 ± 28.10

<0.01

Cholesterol (mg/dL)

199.24 ± 39.41

201.03 ± 45.62

199.61 ± 42.95

201.46 ± 42.75

0.76

Direct HDL-cholesterol (mg/dL)

54.96 ± 14.38

53.02 ± 16.13

53.15 ± 15.54

57.15 ± 16.90

<0.01

LDL-cholesterol (mg/dL)

111.00 ± 32.59

117.08 ± 37.38

116.48 ± 36.58

114.50 ± 36.59

0.48

Triglycerides (mg/dL)

153.18 ± 98.98

159.22 ± 117.47

159.46 ± 110.97

159.37 ± 108.93

0.81

eGFR (mL/min/1.73 m2)

81.14 ± 27.80

80.81 ± 25.29

77.11 ± 20.91

73.37 ± 20.86

<0.01

Uric acid (mg/dL)

6.15 ± 1.70

5.64 ± 1.45

5.58 ± 1.47

5.48 ± 1.45

<0.01

C-reactive protein (mg/dL)

0.84 ± 1.39

0.55 ± 0.66

0.50 ± 0.80

0.49 ± 0.96

<0.01

  1. Mean ± SD for continuous variables: P-value was calculated by weighted linear regression model